A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
List view / Grid view
Translational Genomics Research Institute (TGen)
According to researchers, an interaction between host microRNA and SARS-CoV-2 could be responsible for the range of disease severities.
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
13 November 2015 | By Victoria White
PPF works to limit the spread of glioblastoma multiforme by targeting a protein called TROY...